FDA.reportPublic FDA data

Versacloz 50 MG/ML Oral Suspension

RxCUI
1369831
RxNorm name
Versacloz 50 MG/ML Oral Suspension
Display name
Versacloz 50 MG/ML Oral Suspension
Full name
Versacloz 50 MG/ML Oral Suspension
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:50

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
VERSACLOZCLOZAPINETruPharma LLC2592c9a8-fd74-4e0d-a895-b07b014cf3552025-06-23Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1369831

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
2592c9a8-fd74-4e0d-a895-b07b014cf355Versacloz 50 MG in 1 mL Oral Suspension [PSN] · clozapine 50 MG/ML Oral Suspension [Versacloz] [SBD] · Versacloz 50 MG per 1 ML Oral Suspension [SY] · Versacloz 50 MG/ML Oral Suspension [SY]46These highlights do not include all the information needed to use VERSACLOZ ® safely and effectively. See full prescribing information for VERSACLOZ ®. VERSACLOZ (clozapine) oral suspension Initial U.S. Approval: 198920250623